City

Bordeaux (1)

Brest (1)

Lyon (1)

Montpellier (1)

Paris (1)

Toulouse (1)

Villejuif (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Institut Bergonie (1)

Collaborator

Bayer (1)

Merck KGaA, Darmstadt, Germany (1)

Intervention

phase 1 : avelumab (1)

phase 1 : regorafenib (1)

phase 2 : avelumab (1)

phase 2 : regorafenib (1)

phase 2: low-dose regorafenib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

oesophageal or gastric carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Colorectal Cancer Not MSI-H or MMR-deficient, GIST, Oesophageal or Gastric Carcinoma Trial in France (Phase 1 : Regorafenib,

Recruiting

Colorectal Cancer Not MSI-H or MMR-deficient
+9 more

Phase 1 : Regorafenib
+4 more

Bordeaux, France
+6 more

Dec 6, 2021